Developing a sound regulatory strategy, in-depth understanding of the country or region-specific regulatory requirements for specific product categories, along with accurate interpretations, implications, and applicability of such regulations, are instrumental in achieving a global outreach for medical products. Whether the product is a medical device, diagnostics, biologics, or a pharmaceutical drug, a careful consideration of the regulatory strategy early on is crucial for securing timely clearances or approvals.
ACL Digital Life Sciences Regulatory Services include expert consultation in building a robust global regulatory strategy and support in executing the strategy, which can range from early engagement with Health Authorities, Agencies, or Notified Bodies to Regulatory filings and response to RFIs.
-
Regulatory Consulting
- IDMP / Consulting
- Regulatory Post Market Compliance Support
- IVDR Consulting
- Strategic Support for Successful Submission
- Regulatory Intelligence
- Medical Device Consulting
- Handling Queries from Health Authorities
-
Regulatory Writing for Pharmaceuticals
- Clinical Overviews (eCTD Module 2.5)
- Clinical Summaries (eCTD Module 2.7)
- Clinical Study Report (eCTD Module 5)
- Strategic Labelling, Publishing
- Protocols, ICF, Case Record Forms
-
Regulatory Writing for Medical Devices
- EU MDR Gap Analysis
- UDI Consulting
- CER / CEP Writing
- Post Market Surveillance
- Post Clinical Follow Up Activities